Condensation of muscimol or thiomuscimol with aminopyridazines yields GABA-A antagonists

J Med Chem. 1992 Oct 30;35(22):4092-7. doi: 10.1021/jm00100a015.

Abstract

Ten analogs of muscimol and thiomuscimol in which the amino function was delocalized in an amidinic system were prepared by N2 alkylation of 6-aryl-3-aminopyridazines with (chloromethyl)isoxazole or (chloromethyl)isothiazole derivatives. These muscimol and thiomuscimol derivatives show potent binding properties for GABA-A receptors (they displace [3H]GABA and [3H]gabazine) and provoke convulsions after iv injections. They fit well with the model pharmacophore proposed by our group for the GABA-A antagonists and show similar structure-activity profiles to that of the pyridazinyl-GABAs.

MeSH terms

  • Animals
  • Binding, Competitive
  • Convulsants / chemical synthesis
  • Female
  • GABA-A Receptor Antagonists*
  • In Vitro Techniques
  • Mice
  • Models, Molecular
  • Molecular Conformation
  • Muscimol / analogs & derivatives*
  • Muscimol / chemical synthesis
  • Muscimol / metabolism
  • Muscimol / pharmacology
  • Pyridazines / chemical synthesis*
  • Pyridazines / metabolism
  • Pyridazines / pharmacology
  • Radioligand Assay
  • Rats
  • Receptors, GABA-A / metabolism
  • Structure-Activity Relationship

Substances

  • Convulsants
  • GABA-A Receptor Antagonists
  • Pyridazines
  • Receptors, GABA-A
  • Muscimol
  • thiomuscimol